DE10345875A1 - Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Vewendung und Verfahren zu ihrer Herstellung - Google Patents
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Vewendung und Verfahren zu ihrer Herstellung Download PDFInfo
- Publication number
- DE10345875A1 DE10345875A1 DE10345875A DE10345875A DE10345875A1 DE 10345875 A1 DE10345875 A1 DE 10345875A1 DE 10345875 A DE10345875 A DE 10345875A DE 10345875 A DE10345875 A DE 10345875A DE 10345875 A1 DE10345875 A1 DE 10345875A1
- Authority
- DE
- Germany
- Prior art keywords
- bicyclic heterocycles
- preparation
- methods
- pharmaceutical compositions
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Die vorliegende Erfindung betrifft bicyclische Heterocyclen der allgemeinen Formel DOLLAR F1 in der DOLLAR A R·a·, R·b·, R·c·, R·d· und X wie im Anspruch 1 definiert sind, deren Tautomere, deren Stereoisomere, deren Gemische und deren Salze, insbesondere deren physiologisch verträgliche Salze, mit anorganischen oder organischen Säuren, welche wertvolle pharmakologische Eigenschaften aufweisen, insbesondere eine Hemmwirkung auf die durch Tyrosinkinasen vermittelte Signaltransduktion, deren Verwendung zur Behandlung von Krankheiten, insbesondere von Tumorerkrankungen sowie der benignen Prostatahyperplasie (BPH), von Erkrankungen der Lunge und der Atemwege und deren Herstellung.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10345875A DE10345875A1 (de) | 2003-09-30 | 2003-09-30 | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Vewendung und Verfahren zu ihrer Herstellung |
US10/947,854 US7456189B2 (en) | 2003-09-30 | 2004-09-23 | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
PCT/EP2004/010723 WO2005033096A1 (de) | 2003-09-30 | 2004-09-24 | Chinolin- und chinazolin-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
JP2006530024A JP2007507445A (ja) | 2003-09-30 | 2004-09-24 | キノリン及びキナゾリン誘導体、これを含む薬物、その使用及びその調製方法 |
CA2540501A CA2540501C (en) | 2003-09-30 | 2004-09-24 | Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof |
EP04765571A EP1670781A1 (de) | 2003-09-30 | 2004-09-24 | Chinolin- und chinazolin-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10345875A DE10345875A1 (de) | 2003-09-30 | 2003-09-30 | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Vewendung und Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10345875A1 true DE10345875A1 (de) | 2005-04-21 |
Family
ID=34353273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10345875A Withdrawn DE10345875A1 (de) | 2003-09-30 | 2003-09-30 | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Vewendung und Verfahren zu ihrer Herstellung |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1670781A1 (de) |
JP (1) | JP2007507445A (de) |
CA (1) | CA2540501C (de) |
DE (1) | DE10345875A1 (de) |
WO (1) | WO2005033096A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1731511B1 (de) | 1999-06-21 | 2015-08-12 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
EP3173084B1 (de) | 2005-11-11 | 2019-10-23 | Boehringer Ingelheim International GmbH | Chinazolinderivate zur behandlung von krebserkrankungen |
WO2008023720A1 (fr) * | 2006-08-23 | 2008-02-28 | Astellas Pharma Inc. | COMPOSÉ D'URÉE OU SEL DUDIT COMPOSé |
RU2492864C2 (ru) | 2006-09-18 | 2013-09-20 | Бёрингер Ингельхайм Интернациональ Гмбх | Способ лечения рака, несущего мутации egfr |
US9545381B2 (en) | 2009-07-06 | 2017-01-17 | Boehringer Ingelheim International Gmbh | Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient |
KR101317809B1 (ko) | 2011-06-07 | 2013-10-16 | 한미약품 주식회사 | 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물 |
KR20140096571A (ko) * | 2013-01-28 | 2014-08-06 | 한미약품 주식회사 | 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법 |
US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT892789E (pt) * | 1996-04-12 | 2002-07-31 | Warner Lambert Co | Inibidores irreversiveis de quinases de tirosina |
ID29800A (id) * | 1999-02-27 | 2001-10-11 | Boehringer Ingelheim Pharma | Turunan-turunan 4-amino-kinazolin dan kinolin yang mempunyai efek inhibitor pada transduksi signal yang dimediasi oleh tirosin kinase |
DE19911509A1 (de) * | 1999-03-15 | 2000-09-21 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
EP1731511B1 (de) * | 1999-06-21 | 2015-08-12 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
EP1296973B1 (de) * | 2000-06-24 | 2008-11-05 | AstraZeneca AB | Guanidin-derivate von chinazoin zur behandlung von autoimmunkrankheiten |
DE10042059A1 (de) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
DE10042058A1 (de) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
JP2004514718A (ja) * | 2000-11-02 | 2004-05-20 | アストラゼネカ アクチボラグ | 抗癌剤としての置換キノリン類 |
GB0126433D0 (en) * | 2001-11-03 | 2002-01-02 | Astrazeneca Ab | Compounds |
ATE557008T1 (de) * | 2002-03-30 | 2012-05-15 | Boehringer Ingelheim Pharma | 4- ( n-phenylamino ) -chinazoline/chinoline als tyrosinkinaseinhibitoren |
-
2003
- 2003-09-30 DE DE10345875A patent/DE10345875A1/de not_active Withdrawn
-
2004
- 2004-09-24 WO PCT/EP2004/010723 patent/WO2005033096A1/de active Application Filing
- 2004-09-24 JP JP2006530024A patent/JP2007507445A/ja active Pending
- 2004-09-24 EP EP04765571A patent/EP1670781A1/de not_active Withdrawn
- 2004-09-24 CA CA2540501A patent/CA2540501C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1670781A1 (de) | 2006-06-21 |
CA2540501C (en) | 2012-05-22 |
CA2540501A1 (en) | 2005-04-14 |
WO2005033096A1 (de) | 2005-04-14 |
JP2007507445A (ja) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50106698D1 (de) | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
MY127771A (en) | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them | |
CA2368059A1 (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
EP1784388B8 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
EP2682138A3 (de) | Verbesserte arzneimittelbeschichtete Medizinprodukte, deren Herstellung und Verwendung | |
TW200505912A (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
WO2004099168A3 (en) | Substituted carboxylic acids | |
YU49603A (sh) | Derivati hinazolina, lekovi koji sadrže ova jedinjenja, njihova primena i postupak za njihovo pripremanje | |
ATE373018T1 (de) | Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung | |
WO2010057112A3 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
BR0309167A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito afetado por uma condição patológica ou doença e produto de combinação | |
UA101357C2 (ru) | Спирогетероциклы, лекарственное средство, которое содержит эти соединения, их применение | |
EP1916254A3 (de) | 17alpha-Alkyl-17beta-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17beta-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate | |
TW200510341A (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
DE10345875A1 (de) | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Vewendung und Verfahren zu ihrer Herstellung | |
MX2009007610A (es) | Heterociclicos biciclicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion. | |
DE602004015406D1 (de) | Verwendung von 3-methoxy-pregnenolon bei der herstellung eines arzneimittels zur behandlung von neurodegenerativen erkrankungen | |
ATE389654T1 (de) | Cycloalkyl substituierte 7-amino-4-chinolon-3- carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
EP1738781A3 (de) | Verwendung von Propolis als Beschichtungmaterial für medizinische Implantate | |
DE50008032D1 (de) | Pharmazeutische zusammensetzung aus spinnengiften sowie deren herstellung und verwendung zur behandlung von tumorerkrankungen | |
DE50204789D1 (de) | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
WO2005085466A3 (en) | Diagnostic and therapeutics for diseases associated with rho-associated protein kinase 2 (rock2) | |
ATE492285T1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
WO2004097358A3 (en) | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) | |
ATE497958T1 (de) | Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8141 | Disposal/no request for examination |